A Study of Samuraciclib in Combination With Fulvestrant in Metastatic or Locally Advanced Breast Cancer in Adult Participants
Clinical trial NCT05963984 · COMPLETED
Trial details
- NCT number
- NCT05963984
- Sponsor
- Carrick Therapeutics Limited
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-16
- Primary completion
- 2025-03-20
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.